Key result
Long-term follow-up of new-generation drug-eluting stents is imperative, as demonstrated by a non-significant difference in stent thrombosis between EES and SES at 3 years.
Answers are grounded in this paper and cite their sources.
Long-term follow-up of new-generation drug-eluting stents is imperative to accurately evaluate the incidence of rare but catastrophic late adverse phenomena such as stent thrombosis.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kengo Tanabe (2018) conducted an editorial in Coronary artery disease. Everolimus-eluting stents vs. Sirolimus-eluting stents was evaluated on Definite or probable stent thrombosis (p=0.08). Long-term follow-up of new-generation drug-eluting stents is imperative, as demonstrated by a non-significant difference in stent thrombosis between EES and SES at 3 years.
Synapse has enriched 10 related papers. Consider them for comparative context: